Manchester drug discovery group C4X Discovery has signed an exclusive worldwide licensing agreement with Sanofi, the French pharmaceutical giant, worth up to £360m.

Under the license, Sanofi will develop and commercialise an oral therapy for the treatment of inflammatory diseases, ‘a multi-billion dollar market.’

Manchester drug discovery group C4X Discovery has signed an exclusive worldwide licensing agreement with Sanofi, the French pharmaceutical giant, worth up to £360m.

Read more.

Categories: Industry News